TABLE 3

BPND Estimates of 11C-Raclopride Before and After PVC in Normal Human Striatum for Various RCzmin Thresholds Used to Define ROI Spatial Extent

BPND*
CaudatePutamen
Threshold (%)ObservedAfter PVCObservedAfter PVC
502.18 ± 0.353.34 ± 0.602.87 ± 0.493.96 ± 0.82
752.45 ± 0.393.37 ± 0.603.09 ± 0.543.97 ± 0.83
902.64 ± 0.433.37 ± 0.603.30 ± 0.603.93 ± 0.83
  • * Mean ± SD over 88-subject group.

  • Significant difference across observed values (t test, P < 0.01).

  • No significant difference across PVC values (t test, P > 0.95).